ATMOSR

AtmosR PATENTED TECHNOLOGY consists of small molecule HSP90 inhibitors specially designed to treat brain disorders presenting with protein aggregation... Originally created by patient families, AtmosR works daily in close proximity with the best world experts from academia and private laboratories, in order to best meet patient communities needs.

Primary location: Fuveau France